Clinical Trials Browser

OTHER × Carcinoma, Neuroendocrine × Capecitabine × Clear all

NCT03387592 2025-03-10

SENECA

Phase 2 Terminated

Carcinoma, Neuroendocrine

NCT03079440 2022-12-06

TEMCAP in Grade 3 and Low Ki-67 Gastroenteropancreatic Neuroendocrine Tumors

Phase 2 Completed

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT01203306 2010-09-16

XELBEVOCT

Phase 2 Unknown

Carcinoma, Neuroendocrine, Neuroendocrine Tumors